Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

by | Jun 8, 2026 | Economy_finances

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments